The second-largest TMDC-based biomedical application lies in the blue cluster. It is obvious that TMDCs for cancer theranostics is its research focus, as validated by the frequently occurred keywords like PTT, nanomaterial, drug delivery, cancer, theranostics, synergistic therapy, RT, photodynamic therapy (PDT), chemodynamic therapy (CDT), bioimaging, PAI, CT, magnetic resonance imaging (MRI),
etc. Theranostics refers to the combination of imaging techniques with therapeutic modalities, which holds great promise for precise and efficient cancer diagnosis and treatment [
71]. Benefiting from their versatile properties including high photoabsorption ability, photothermal conversion efficiency and photostability, TMDCs are superior candidates for cancer theranostics, especially for PAI-guided PTT. However, to obtain a better cancer eradicating capability, the photothermal performance of TMDC-based platform should be further improved. Over the years, researchers have developed various strategies aimed at improving TMDCs' photothermal traits. For example, besides the most representative MoS
2 nanosheets, TMDCs with novel chemical compositions such as WS
2, WSe
2, MoSe
2, TiS
2, ReS
2, have been explored for PAI and/or PTT [
72-
76]. In addition, modulating the morphology of TMDCs is regarded as another useful strategy to promote their theranostic performance. Apart from regular nanosheets, TMDC-based nanodots, nanorods, flower-like nanoflakes, hollow spheres, radar-like nanoparticles,
etc. have been reported to date. Distinct morphology can have great impacts on their surface-to-volume ratio and strain-related defects, thus enhancing their photothermal conversion efficiency [
5,
77-
79]. Furthermore, integration of semiconducting TMDCs with noble metals to form plasmonic nanoagent [
80], construction of TMDC-based composite/hybrid [
10,
81] and functionalization with coatings such as polydopamine [
82] have also shown effectiveness in promoting PAI/PTT efficacy. Similarly, the good inherent optical and/or electronical properties such as great photo-harvest ability and strong photoluminescence make TMDCs suitable for PDT and fluorescence imaging (FI) applications [
83-
85]. Upon light irradiation, TMDCs with a narrow bandgap and good photoelectric conversion ability can be activated and react with the surrounding oxygen to form singlet oxygen, and thus serve as inherent photosensitizers [
85,
86]. However, pristine TMDCs suffer from relatively poor ROS generation efficiency and inherent ROS scavenging capability due to their abundant defects, unpaired electrons and edge sites [
15]. Therefore, pristine TMDCs are not perfectly suitable for PDT, and thus additional functionalization is required in order to improve their PDT performance. Besides their promising thermal, optical and electronical attributes, TMDC-based nanomaterials provide great opportunities for CT and/or RT. This application can be attributed to their containment of high atomic elements such as Re (75), W (74), Ta (73) and Mo (42), which endow them with superior X-ray attenuation capability, thereby enhancing their CT/RT performance [
73,
87-
90]. Given all this, versatile TMDCs are highly appealing as multifunctional platforms for combinational therapy, which can be achieved without relying on other additional materials. By far, PTT/RT has been identified as one of the reasonable paradigms of W or Re element containing TMDC-based nanocomposite [
10,
91,
92]. More recently, potent anticancer effects on both primary and distant cancer cells have been achieved by further combining PTT/RT with immunotherapy [
93,
94]. For instance, Dong et al. recently reported the combinational PTT/RT/checkpoint blockade immunotherapy (CBT) strategy based on WO
2.9-WSe
2-PEG NPs (WSP). In detail, WSP possess strong photothermal ability to kill radioresistant cancer cells and meanwhile improve the tumor oxygenation to further facilitate RT. Moreover, WSP with high atomic W elements exhibit high X-ray attenuation ability which can overcome PTT's penetration depth limitation and kill tumor cells in deep sites. Together with the heterojunction structure, it can effectively catalyze hydrogen peroxide in the tumor microenvironment under X-ray irradiation, thus achieving enhanced RT. Notably, both ROS generated by RT and hyperthermia derived from PTT can enhance tumor immunogenicity and hence benefit CBT. Meanwhile, CBT can offset the weakness of RT/PTT towards combating distant cancer cells. Finally, this strategy fulfilled the eradication of both local and metastatic tumors with lower radiation and NIR light dose and high anticancer efficiency (Fig. S4 in Supporting information).